BDNF and neuroblastoma: In this work, we characterized a cell model of Parkinson’s disease based on SH-SY5Y neuroblastoma cells with stable alpha-synuclein overexpression, which were differentiated towards dopaminergic neuronal phenotype by sequential addition of RA + BDNF.